Page last updated: 2024-11-01

niclosamide and Trypanosomiasis, African

niclosamide has been researched along with Trypanosomiasis, African in 1 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Trypanosomiasis, African: A disease endemic among people and animals in Central Africa. It is caused by various species of trypanosomes, particularly T. gambiense and T. rhodesiense. Its second host is the TSETSE FLY. Involvement of the central nervous system produces African sleeping sickness. Nagana is a rapidly fatal trypanosomiasis of horses and other animals.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Merschjohann, K1
Steverding, D1

Other Studies

1 other study available for niclosamide and Trypanosomiasis, African

ArticleYear
In vitro trypanocidal activity of the anti-helminthic drug niclosamide.
    Experimental parasitology, 2008, Volume: 118, Issue:4

    Topics: Animals; Anthelmintics; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; HL-60 Cells;

2008